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INVITED COMMENTARY
Thomas S. Huber, MD, Gainesville, Fla
The authors report a randomized, controlled trial comparing
autogenous radiocephalic and prosthetic forearm accesses in pa-
tients with compromised vessels for the autogenous choice. They
should be commended for their efforts and study design given the
limited evidence in the literature to justify the choice of the various
access configurations. Indeed, the paucity of level 1 evidence is
staggering given the overwhelming number of patients on hemo-
dialysis in the United States and abroad. The authors found that
the primary (33% vs 44%) and secondary (52% vs 79%) annual
patency rates were higher for the prosthetic accesses, although the
associated complication (1.19 patients per year) and intervention
(0.94 patients per year) rates were also greater. These results are
not particularly surprising given the study inclusion criteria for the
autogenous access (radial artery diameter between 1 and 2 mm
and/or cephalic vein 1.6 mm) and the mean diameters for the
brachial artery (3.8 mm) and the cephalic vein (3.1 mm) in the
prosthetic group.
It is not particularly clear how the results of the study should
affect our clinical practices. Extending the indications for the
autogenous radiocephalic access to patients with compromised
vessels affords another access option that does not preclude a
subsequent prosthetic forearm access. However, there is a signifi-
cant downside to accesses that never mature sufficiently for cannu-
lation, including the prolonged use of temporary catheters among
the patients already on hemodialysis and the associated economic/
psychologic effects. Indeed, the increased emphasis on autogenous
accesses in the United States has resulted in the unintended con-
sequence of increasing their primary failure rates (nonmaturation).
The more pivotal question that merits a randomized, con-
trolled trial is the choice between a prosthetic forearm loop or an
autogenous brachiobasilic access given the K/DOQI that recom-
mend the autogenous radiocephalic and brachiocephalic routes as
their first and second access choices, respectively. The results of the
current study can be used to reach the opposite conclusion and
seem to justify extending the indications for autogenous radioce-
phalic access to these compromised patients. Indeed, the patency
rates for the autogenous and prosthetic accesses seem to parallel
each other after the initial failures are excluded, and it is conceiv-
able that the longer-term patency rates (1 year) for the autoge-
nous accesses may be superior. Furthermore, the results under-
score the importance of pre–end-stage renal disease care and the
importance of early referral to an access surgeon before initiating
dialysis to allow adequate time to achieve an effective access. It is
imperative to realize that maintaining an effective hemodialysis
access is a difficult problem that usually requires multiple proce-
dures and interventions and lifelong planning.
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